Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Howard Lipton

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
JACC. Cardiooncology|August 14, 2025
Cardiovascular Disease in Patients With Chronic Myeloid Leukemia: JACC: CardioOncology State-of-the-Art ReviewNazanin Aghel, Jeffrey Howard Lipton
Vascular Health and Risk Management|August 24, 2017
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillanceNazanin Aghel, Diego Hernan Delgado, Jeffrey Howard Lipton
Leukemia|September 12, 2018
Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines?Nazanin Aghel, Diego Hernan Delgado, Jeffrey Howard Lipton
European Journal of Haematology|November 7, 2019
Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumabMaria Queralt Salas, Ali Alahmari, Jeffrey Howard Lipton
Leukemia & Lymphoma|July 9, 2016
Pregnancy: part of life in chronic myelogenous leukemiaArjun Datt Law, Dennis Dong Hwan Kim, Jeffrey Howard Lipton
Leukemia & Lymphoma|September 30, 2016
Reply to letter to the editorArjun Datt Law, Dennis Dong Hwan Kim, Jeffrey Howard Lipton
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2017
Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-upNazanin Aghel, Jeffrey Howard Lipton, Eshetu G Atenafu, et al.
European Journal of Haematology|November 10, 2023
Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation after time-dependent discontinuation of prophylaxisVered Stavi, Nihar Desai, Fotios V Michelis, et al.
European Journal of Haematology|November 19, 2019
Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survivalShruti Prem, Eshetu G Atenafu, Wilson Lam, et al.
European Journal of Haematology|August 8, 2019
Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host diseaseShruti Prem, Zeyad Al-Shaibani, Fotios V Michelis, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
JACC. Cardiooncology|August 14, 2025
Cardiovascular Disease in Patients With Chronic Myeloid Leukemia: JACC: CardioOncology State-of-the-Art ReviewNazanin Aghel, Jeffrey Howard Lipton
Vascular Health and Risk Management|August 24, 2017
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillanceNazanin Aghel, Diego Hernan Delgado, Jeffrey Howard Lipton
Leukemia|September 12, 2018
Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines?Nazanin Aghel, Diego Hernan Delgado, Jeffrey Howard Lipton
European Journal of Haematology|November 7, 2019
Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumabMaria Queralt Salas, Ali Alahmari, Jeffrey Howard Lipton
Leukemia & Lymphoma|July 9, 2016
Pregnancy: part of life in chronic myelogenous leukemiaArjun Datt Law, Dennis Dong Hwan Kim, Jeffrey Howard Lipton
Leukemia & Lymphoma|September 30, 2016
Reply to letter to the editorArjun Datt Law, Dennis Dong Hwan Kim, Jeffrey Howard Lipton
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2017
Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-upNazanin Aghel, Jeffrey Howard Lipton, Eshetu G Atenafu, et al.
European Journal of Haematology|November 10, 2023
Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation after time-dependent discontinuation of prophylaxisVered Stavi, Nihar Desai, Fotios V Michelis, et al.
European Journal of Haematology|November 19, 2019
Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survivalShruti Prem, Eshetu G Atenafu, Wilson Lam, et al.
European Journal of Haematology|August 8, 2019
Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host diseaseShruti Prem, Zeyad Al-Shaibani, Fotios V Michelis, et al.
Pageof 5